In a recent study, Dai et al. [36] constructed two tumour-specific oncolytic adenoviruses coding for Bim (Ad-Bim) or truncated Bid (Ad-tBid) and performed gain-of-function assays in nine ovarian cancer cell lines. This evidence concerns the gene BID and ovarian cancer.